D-0425-2025 Class II Terminated

Recalled by KENIL HEALTHCARE PRIVATE LIMITED — Ta. Kadi, District Mehsana, N/A

FDA drug recall D-0425-2025 was initiated by KENIL HEALTHCARE PRIVATE LIMITED on Apr 24, 2025 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Feb 19, 2026). Affected quantity: 16,248 Jars.

Recall details

Product Type
Drugs
Report Date
May 28, 2025
Initiation Date
Apr 24, 2025
Termination Date
Feb 19, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
16,248 Jars

Product description

KOFAL Original, Penetrating Pain Relieving Ointment (methyl salicylate 12% - Topical Analgesic), 4 oz (113 g) Jar, Distributed by: Pharmadel LLC, Georgetown, DE 199747, NDC 55758-106-04, UPC 8 9971100128 0.

Reason for recall

CGMP Deviations

Distribution pattern

DE and NC

Code information

Lost SP21A, Exp Date: 03/31/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0425-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0425-2025. Report a data issue: hello@regdatalab.com.